Anticholinergics Associated with Longer Hospital Stays
the Psychiatry Advisor take:
Anticholinergic drugs, commonly used to treat conditions ranging from bladder problems to depression and insomnia, can cause cognitive impairment that may interfere with rehabilitation efforts and prolong hospital stay for patients recovering from brain and spinal chord injuries.
Researchers from the British National Health Service and Aston University's School of Life & Health Sciences in the United Kingdom examined the way the side effects of anticholinergics impacted 52 patients with brain or spinal injury being treated at a neuro-rehabilitation unit.
The average length of hospital stay was longer among those with higher levels of anticholinergic drug burden (ACB) and shorter among those with lower ACB, the researchers found.
"This pilot study demonstrates the need for larger studies to confirm the results and need for further investigation into what long-term effects these common medications are having on the recovery of these patients," the researchers wrote.
In addition to the clinical implications on patient quality of life such findings may have, patient discharge rates are often tied to financial incentives for hospitals, raising questions about wider efficiencies in the healthcare system.
Anticholinergics may delay recovery from brain injury.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Psychopathology of Adults Affected by Pre- and Perinatal Factors, Family Functioning
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- Anxiety: Feature of Late-Onset Dementia or Modifiable Risk Factor?
- New APA President Takes Office as the First African-American to Lead the Organization
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- New Dimensions in Psychopathy: Are There Cultural Differences in Psychopaths?
- Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases
- Exploring the Link Between Persistent Infection, Inflammation, and Mood Disorders
- CDC: No Change in Level of Uninsured in US in 2017
- Benefit of Behavioral Activation During TMS for Major Depressive Disorder